Christine Simmon, Executive Director of AAM’s Biosimilars Council, reacts to the recent release of FDA’s Biosimilars Action Plan
Sign-Up for our Newsletter
Sign-up for our newsletter *
Copyright © 2018 The Biosimilars Council, All rights reserved.
The Biosimilars Council is a division of the
Association for Accessible Medicines.